Ranbaxy jumps after final nod from USFDA to launch Lipitor

Ranbaxy’s shares jumped over 10% in morning trade on Thursday after it said it has launched its generic version of Lipitor in the US market having received final approval from US Food and Drugs Administration (FDA).

December 01, 2011 / 15:15 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol Bureau

Shares of Ranbaxy Laboratories jumped 10% on opening on Thursday after it said it has launched its generic version of Lipitor in the US market having received final approval from US Food and Drugs Administration (FDA).

The pharma major, owned by Japan

first published: Dec 1, 2011 10:34 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.